Results 21 to 30 of about 55,766 (252)
Factors Influencing Fluoroquinolone Resistance
Emerging Infectious Diseases, 2003 To the Editor: Recently, Scheld summarized factors that he considered to have an influence on the efficacy of fluoroquinolones (1). In the review, ciprofloxacin was presented as the most active fluoroquinolone against Pseudomonas aeruginosa with MICs typically two- to eightfold lower than those for levofloxacin, moxifloxacin, or gatifloxacin.
Daniel F. Sahm +3 more
doaj +3 more sources
Emerging Mechanisms of Fluoroquinolone Resistance [PDF]
Emerging Infectious Diseases, 2001 Broad use of fluoroquinolones has been followed by emergence of resistance, which has been due mainly to chromosomal mutations in genes encoding the subunits of the drugs' target enzymes, DNA gyrase and topoisomerase IV, and in genes that affect the ...
David C. Hooper
doaj +3 more sources
Fluoroquinolone Resistance in Campylobacter Absent from Isolates, Australia [PDF]
Emerging Infectious Diseases, 2003 Fluoroquinolone resistance was detected in 12 of 370 Australian human Campylobacter isolates; 10 of these were travel-associated, and for 2 isolates travel status was unknown. No resistance was found in isolates known to be locally acquired. In Australia,
Leanne Unicomb +3 more
doaj +2 more sources
Intrinsic fluoroquinolone resistance in Orientia tsutsugamushi
International Journal of Antimicrobial Agents, 2010 Scrub typhus is a public health concern for a population of over a billion humans, with an estimated incidence of one million cases/year in endemic areas. Although doxycycline remains the standard therapy, fluoroquinolones have been used successfully in a few patients.
Wiwit Tantibhedhyangkul +2 more
exaly +5 more sources
Mycoplasma genitalium infections can comprise a mixture of both fluoroquinolone-susceptible and fluoroquinolone-resistant strains [PDF]
, 2021 BACKGROUND: Mycoplasma genitalium was recently added to the CDC's antimicrobial resistance threats 'watch list', as it has rapidly become resistant to mainstay treatments.
Bletchly, Cheryl +4 more
core +1 more source
Trend of multidrug and fluoroquinolone resistance in Mycobacterium tuberculosis isolates from 2010 to 2014 in Korea: a multicenter study [PDF]
The Korean Journal of Internal Medicine, 2019 Background/Aims This study was conducted to evaluate the recent prevalence and trend of anti-tuberculosis (TB) drug resistance with a focus on multidrug-resistance (MDR) and fluoroquinolone resistance in South Korea.
Hyeonseok Kim +7 more
doaj +1 more source
Fluoroquinolone Resistance in Escherichia coli Causing Community-Acquired Urinary Tract Infections: A Systematic Review. [PDF]
MicroorganismsCommunity-acquired urinary tract infections account for 15% of all outpatient use of antibiotics, and women are primarily affected; the major causative microorganism is uropathogenic Escherichia coli (E. coli).
Ruiz-Lievano AP +5 more
europepmc +2 more sources
Predicting fluoroquinolone resistance in Mycobacterium tuberculosis [PDF]
, 2023 Tuberculosis killed an estimated 1.5 million people in 2020 and the spread of drug-resistant strains is an increasing threat. Fluoroquinolones are among the safest and most effective drugs used to treat drug-resistant tuberculosis, but fluoroquinolone ...
Brankin, Alice E.
core +2 more sources
Indian Journal of Ophthalmology, 2022 Purpose: To assess the fluoroquinolone resistance pattern and trends among bacterial isolates from ocular infections over a 16-year period and explore alternative antibiotics in fluoroquinolone-resistant strains.
Samrat Chatterjee +5 more
doaj +1 more source
Antibiotics, 2020 The efficacy of fluoroquinolone-based eradication therapy largely depends on the fluoroquinolone resistance of H. pylori. The aim of this study was to investigate the changes in the primary resistance rate of H.
Su Yeon Rhie +5 more
doaj +1 more source